It has been well established that T lymphocytes can be triggered by antigen interacting with the T cell antigen receptor (TcR)' or by antibodies binding to the associated structure CD3 . Recent findings (1) suggest the existence of alternative pathways of T lymphocyte activation. Certain mAbs to the cell surface molecule CD2 (T11, LFA-2) activate T lymphocytes. T lymphocyte activation is dependent on the epitope recognized by the anti-CD2 mAb. mAbs to a number of other surface antigens provide a costimulatory signal . mAbs to CD5 (Tp67) (2) and CDw28 (Tp44) (3) augment T lymphocyte proliferation and IL-2 production. In the presence of PMA, mAbs to Tp44 stimulate purified T lymphocytes directly (3). We report here that an mAb to the surface protein sialophorin stimulates T lymphocyte proliferation in a manner similar to mAbs to CD3 and CD2 .
It has been well established that T lymphocytes can be triggered by antigen interacting with the T cell antigen receptor (TcR)' or by antibodies binding to the associated structure CD3 . Recent findings (1) suggest the existence of alternative pathways of T lymphocyte activation. Certain mAbs to the cell surface molecule CD2 (T11, LFA-2) activate T lymphocytes. T lymphocyte activation is dependent on the epitope recognized by the anti-CD2 mAb. mAbs to a number of other surface antigens provide a costimulatory signal . mAbs to CD5 (Tp67) (2) and CDw28 (Tp44) (3) augment T lymphocyte proliferation and IL-2 production. In the presence of PMA, mAbs to Tp44 stimulate purified T lymphocytes directly (3) . We report here that an mAb to the surface protein sialophorin stimulates T lymphocyte proliferation in a manner similar to mAbs to CD3 and CD2 .
Sialophorin, previously called gpL 115, was found to be deficient in quantity and/or defective in lymphocytes of patients with the X-linked immunodeficiency Wiskott-Aldrich syndrome (4) (5) (6) . A molecule indistinguishable from sialophorin of normal lymphocytes was purified to homogeneity from cells of the lymphoblastoid cell line CEM (6, 7) . Sialophorin of CEM cells consists of >50% carbohydrate, primarily -100 0-linked units of sialic acid, galactose, and galactosamine, and a single -520-amino-acid polypeptide chain rich in serine, threonine, and proline (7, 8) .
In this report, the mAb L10 which recognizes a surface epitope of sialophorin (6) was used to investigate the expression and the function of the molecule . Fluorescent staining with mAb indicated that sialophorin is expressed on all cells in the thymus and on a fraction of bone marrow and peripheral blood cells. Functional studies demonstrate that L 10 mAb triggers the proliferation of 
Materials and Methods
Culture Medium . Cells were grown in RPMI 1640 (M .A . Bioproducts, Walkersville, MD) with 10% heat-inactivated FCS, 100 U/ml penicillin, and 100 Ag/ml streptomycin (all from Gibco Laboratories, Grand Island, NY), 10 mM Hepes (Sigma Chemical Co ., St . Louis, MO), and 25 AM 2-ME (Eastman Organic Chemicals, Rochester, NY). The longterm cytolytic T lymphocyte (CTL) line was maintained in 10% human conditioned medium .
IL-2-containing Human Conditioned Medium . IL-2-containing conditioned medium was prepared as described (9) by culturing washed mononuclear cells isolated from plateletpheresis residue at 3 x 106/ml in RPMI 1640 with 3% FCS, 0.15% PHA (Bacto PHA-P; Difco Laboratories, Inc., Detroit, MI), 2 .8 AM indomethacin (Sigma Chemical Co.), 3 mM lithium chloride, and 50 AM hydroxyurea (Sigma Chemical Co .) . The conditioned medium was collected after 72 h and subjected to fractional precipitation with ammonium sulfate. The 50-75% saturated ammonium sulfate fraction was dialyzed, filter-sterilized, and stored at -20°C.
Cell-Surface Immunofuorescence . Cells were washed twice with PBS containing 2.5% FCS and 0.02% sodium azide. In dual parameter analysis, the cells were incubated on ice for 30 min with excess fluorescein-and phycoerythrin-conjugated mAb. The cells were washed three times, fixed in 1 % paraformaldehyde and examined on a FACS I analyzer (Becton Dickinson & Co ., Mountain View, CA). In single parameter analysis, the cells were incubated with mAbs, washed and incubated with a 1 :10 dilution of fluoresceinconjugated goat F(ab')2 anti-mouse IgG antibody (FITC-GAM, Tago, Burlingame, CA) on ice for 30 min and were washed and fixed.
Proliferation Assay. Peripheral blood mononuclear cells were isolated by Ficoll/Hypaque centrifugation (Lymphocyte Separation Medium ; Bionetics Laboratory Products, Charleston, SC). Threefold dilutions of cells were cultured in triplicate in round-bottom microtiter wells (Linbro Chemical Co ., Hamden, CT). mAbs were added at the start of the cell culture. The cells were pulsed with 1 ACi [-'H]thymidine per well for 24 h before harvest at 72, 96, or 120 h.
Treatment with mAbs and Complement. Peripheral blood or bone marrow mononuclear cells isolated by Ficoll/Hypaque centrifugation were incubated at 2 x 10'/ml with 10 Ag/ml mAb on ice for 30 min. The cells were pelleted and incubated with rabbit complement (Pel-Freeze Biologicals, Rogers, AR) at a 1 :3 dilution for 1 h at 37°C and then washed . The efficiency of complement lysis was assessed by trypan blue exclusion and immunofluorescence analysis . Monoclonal Antibodies. Hybridoma cells producing mAbs were grown as ascites in BALB/c mice . The antisialophorin mAb L10 is an IgGl which recognizes native and sialidase-treated sialophorin (6) . MMA mAb recognizes the surface molecule MMA on phagocytes (10) . The mAbs defining cell surface molecules associated with T cell activation, 4172 (11) and TS2/7 (anti-VLA-1 ; reference 12), were used at a 1 :200 dilution of hybridoma ascites. Other mAbs were obtained as follows: OKT3, OKTI I (Ortho Pharmaceutical, Raritan, NJ) and Leu-1, Leu-3a, Leu-8, Leu-11, Leu-12, Leu-15, Leu-M3, anti-IL-2-R, and anti-HLA-DR (Becton Dickinson & Co .). Where indicated, IgG was purified from ascites by protein A-Sepharose chromatography (13) .
Preparation of F(ab')2 Antibodies . F(ab')2 fragments were prepared from purified IgG as described (13) . Briefly, 200 Al of papain-Sepharose (gift of Dr . S. Herrmann, DanaFarber Cancer Institute, Boston, MA) was activated with 50 mM cysteine hydrochloride (Sigma Chemical Co .) for 30 min at 37°C. Papain-Sepharose was washed and incubated with purified mAb IgG for 6 h at 37'C . The resin was removed by centrifugation and Fc fragments and intact IgG were separated from F(ab')2 antibodies by Protein A-Sepharose chromatography .
Surface expression of sialophorin on peripheral blood mononuclear cells assessed by dual parameter immunofluorescence. Peripheral blood mononuclear cells were stained with FITC-conjugated L10 mAb (5 fag/ml) .
Phycoerythrin-conjugated mAb added at 5 Wg/ml for the second parameter were: anti-CD4 (Leu-3a), anti-CD8 (Leu-2), anti-CD19 (Leu-12), anti-CD16 (Leu-11), anti-CD11 (Leu-15), and Leu-M3 .
Monocyte Purification. Leukocytes from plateletpheresis residues were washed in culture medium and fractionated by Ficoll/Hypaque centrifugation . The mononuclear cells at 5 x 107/ml in culture medium were placed on a rocker for 30 min at 4°C . Aggregated cells were isolated using unit gravity sedimentation (14) . These cells were underlayered with 3 ml cold FCS and harvested after 15 min of unit gravity sedimentation . The pelleted cells were incubated at 10 7/ml in 75-cm' culture flasks at 37°C for 30 min . The adherent cells were vigorously washed with culture medium . Culture medium containing 20% FCS was added to the remaining adherent cells, which were harvested after culture for 12 h . These purified monocytes were used to reconstitute autologous monocyte-depleted PBMC in proliferation assays .
Results
Distribution of Sialophorin . Previous studies (6) used surface radioiodination to demonstrate sialophorin expression on the surface of lymphocytes and CEM lymphoblastoid cells. To further investigate the distribution of sialophorin, we performed dual-parameter immunofluorescence analysis of peripheral blood cells. Staining of freshly isolated blood mononuclear cells with fluorescein conjugates of the antisialophorin mAb L10 demonstrated that sialophorin is expressed on both CD4+ (T4, Leu-3a) and CD8' (T8, Leu-2) cells (Fig. 1) as well as all CD2+ (TI 1, Leu-5) and CD5+ (TI, Leu-1) T lymphocytes (data not shown) . L 10 staining was also observed on some peripheral B lymphocytes defined by the B cell mAb Leu-12 (anti-CD19) (Fig. 1) . Thus, staining with L10 indicates that sialophorin is expressed on all T lymphocytes and on a subset of B lymphocytes.
In addition, L10 mAb stained 50% of CD11' (Leu-15) peripheral blood mononuclear cells (Fig. 1) . The CD 11 antigen, defined by Leu-15/OKM 1 /Mo1 mAb, is expressed on monocytes, NK cells, and some T lymphocytes (15, 16) . Sialophorin expression on NK cells is indicated by the detection of a population of L 10+ cells that stained with an mAb to the NK marker CD 16 (Leu-11 mAb, anti-Fc receptor) (Fig. 1) . Peripheral blood mononuclear cells that stained with the monocyte marker mAb LeuM3 did not stain with L10 (Fig. 1) .
L10 mAb staining indicated that sialophorin is expressed on virtually all Tymocytes (Table I) . To investigate sialophorin expression on bone marrow cells, the total population was depleted of T cells by treatment with Leu-1 mAb (anti-CD5) and complement. The residual bone marrow cells were CD2-and CD3-. However, 29% of the residual bone marrow cells were L10+, indicating expression of sialophorin (Table I) . L 10 mAb did not stain erythrocytes or other mesenchymal cells, such as primary fibroblasts and a rhabdomyosarcoma cell line RD (data not shown) .
L10 mAb Stimulates the Proliferation of T Lymphocytes. The function of several surface molecules, including LFA-1, CD4, and CD8, was demonstrated by the ability of appropriate mAbs to inhibit CTL and NK function . In the initial functional evaluation of sialophorin, it was observed that, rather than inhibiting CTL and NK function, L 10 mAb augmented cytolytic T cell activity (Table II) . The marginal stimulation of T cells and NK cells in cytotoxicity assays suggested that L 10 mAb might be stimulatory for T lymphocytes.
Purified L 10 mAb was compared with mAbs recognizing other T cell surface antigens for their ability to stimulate T cell proliferation . In multiple experiments, mAbs recognizing the T cell antigens sialophorin and CD3 stimulated >10-fold increase in [ incorporation (Fig. 2) . L10 mAb was comparable to anti-CD3 mAb in its ability to stimulate proliferation . Both L 10 mAb and anti-CD3 mAb stimulated maximal [sH]thymidine incorporation at 72 h (Fig. 3) . The concentration of L10 mAb required for optimal proliferation was 100 ng/ml. Anti-CD3 mAb was more efficient than L10 mAb at stimulating proliferation in the range of 10-100 ng/ml (Fig. 4) . The distribution of sialophorin molecules indicated that L 10 could be stimulating NK cells or B cells, in addition to T cells. To identify the peripheral blood mononuclear cells stimulated by L 10, we used mAbs and complement to deplete various populations. Treatment of peripheral blood mononuclear cells with the pan-T cell mAb Leu-1 (anti-CD5) and complement completely abrogated the proliferative response to L 10 mAb, indicating that peripheral blood T lymphocytes were responsible for [sH]thymidine incorporation (Table III, Exp. A). Similar results were obtained when a combination of anti-CD3 and anti-CD2 mAb and complement were used for cell depletion (data not shown) .
Monocyte Dependence of L10-stimulated Proliferation. When monocytes were depleted from peripheral blood mononuclear cells by treatment with MMA mAb and complement, L10-stimulated proliferation was not observed (Table III, Exp. B), indicating that monocytes are required for stimulation of T lymphocytes by L 10 mAb. This finding suggested that monocytes are needed for monokine production and/or Fc receptor binding of L 10 mAb. F(ab') 2 fragments of L 10 mAb were found to be 50-fold less effective than intact L 10 IgG in stimulating T cell proliferation (Fig. 4) , suggesting that an important contribution of monocytes is binding of intact L 10 mAb via the Fc receptor . The addition of supernatants from PHA-activated mononuclear cells did not restore L10-dependent proliferation to monocyte-depleted T cells (data not shown), suggesting that the monocyte dependence is not due solely to a requisite monokine .
Expression of Activation Antigens after L10 Stimulation. To further investigate the activation of T lymphocytes by L 10, the surface expression of T cell activation antigens was evaluated 5 d after stimulation. The activation antigens HLA-DR, IL-2-R, and 4F2 were induced by L10 mAb, by the anti-CD3 mAb OKT3, and by PHA (Table IV) . None of these agents induced the expression of the late activation antigen VLA-1 . Thus, the induction of early activation antigens by L10 mAb is similar to the induction by anti-CD3 mAb. The anti-CD3 mAb OKT3 effectively modulated the CD3 antigen . In contrast, no modulation of the sialophorin antigen was observed at 5 d.
Fluorescent staining with the mAb L 10 demonstrated that the heavily glycosylated surface protein sialophorin is expressed on all T lymphocytes in peripheral 
Induction of Expression of Activation Antigens
Peripheral blood mononuclear cells were incubated with PHA-P (3,ug/ml), OKT3 mAb (100 ng/ml), and L10 mAb (100 ng/ml) for 5 d. Expression of surface antigens is presented as the MFI of cells stained with the detecting mAb and FITC-GAM with blank fluorescence (cells without mAb) substracted . Parallel cell cultures that were washed twice 48 h before harvest to remove surface-bound antibody gave similar results (data net shown) .
blood and on a subpopulation of B lymphocytes. Sialophorin is also expressed on virtually all thymocytes and some bone marrow cells. Functional studies demonstrated that L 10 mAb stimulates the proliferation of peripheral blood T cells.
The time course and magnitude of mAb-induced T lymphocyte proliferation are similar for sialophorin and CD3. In addition, both molecules require the Fc portion of the antibody for stimulation. Either substitution of F(ab') 2 mAb or depletion of monocytes significantly diminished the proliferative response of T lymphocytes to L10 mAb. The Fc region may be required for binding the mAb to monocytes and presenting it to T cells. As suggested by others (17, 18) , mAb binding by the monocyte Fc receptor may be required to facilitate clustering or aggregation of the corresponding surface antigen.
Surface expression of the activation antigens HLA-DR, IL-2-R, and 4F2 provided an additional measure of T cell activation. The magnitude and time course of expression of activation antigens was similar for cells stimulated by PHA, anti-CD3 mAb, and L10 mAb. The induction of IL-2-R by all three agents suggests a common pathway dependent on IL-2 growth factor .
The failure of the dual-parameter mAb staining experiments to detect sialophorin on peripheral blood Leu-M3+ cells is not readily explainable since another study detected sialophorin expression on isolated monocytes using the technique of immunoblotting with L 10 mAb (19) . Immunoblotting analysis with L10 mAb also demonstrated sialophorin expression on blood neutrophils, lymphocytes, and platelets (19) .
The chemical characteristics of the sialophorin molecule are similar to those of the rat surface molecule defined by W3/13 mAb (20, 21) . Like sialophorin, W3/13 antigen (also called leukocyte sialoglycoprotein) is a heavily glycosylated single-chain polypeptide rich in serine, threonine, and proline with multiple 0-linked carbohydrate units of sialic acid, galactose, and galactosamine (21) . W3/13 mAb was found to stain all thymocytes, T (but not B) lymphocytes, bone marrow neutrophils, and brain cells (20) .
Highly glycosylated surface proteins resembling sialophorin have been de- tected by others on human lymphoid cells (reviewed in references 7 and 8).
Expression of the human sialophorin-like molecule L-LSGP was detected by fluorescent mAb staining on most thymocytes, virtually all T4' and T8+ peripheral blood lymphocytes, and 25% of circulating B lymphocytes, but not on peripheral blood monocytes, neutrophils, and platelets (22) . The association of sialophorin with stimulation of T lymphocytes, on the one hand, and, on the other hand, the defect of sialophorin in lymphocytes of Wiskott-Aldrich syndrome patients suggest intriguing possible relationships . The Wiskott-Aldrich syndrome is an X-linked trait characterized clinically by both lymphocyte and platelet dysfunction. Successful bone marrow transplantation indicates that the defect resides in lymphohematopoietic cells (23) (24) (25) (26) . Structural correlates of the T cell functional defect have been identified in Wiskott-Aldrich syndrome . At the cellular level, gross abnormalities of lymphocyte surface architecture were identified (27) and, at the molecular level, lymphocytes from Wiskott-Aldrich patients were found to be deficient in sialophorin and/or to express defective molecules (5, 6) . The deficiency/defect of the sialophorin molecule in Wiskott-Aldrich syndrome cells and the capacity of sialophorin to function in normal T cell proliferation as reported here suggest the involvement of sialophorin in the pathogenesis of the Wiskott-Aldrich syndrome.
In conclusion, sialophorin has the capacity to function in T cell activation. The antisialophorin mAb L 10 stimulates T cell proliferation in a manner similar to anti-CD3 mAb. Remaining questions concern the identity of the putative physiological ligand for sialophorin, the mode of transmembrane signaling by sialophorin, and the role of sialophorin defects in the Wiskott-Aldrich syndrome .
Summary
The mAb L10 was used to determine the distribution and the function of sialophorin, the heavily glycosylated surface molecule that is deficient/defective in lymphocytes of patients with the X-linked immunodeficiency Wiskott-Aldrich syndrome . Dual-parameter FACS analysis indicated that sialophorin is expressed on CD4+ and CD8+ lymphocytes, on a subpopulation of peripheral blood B lymphocytes, on all thymocytes, and on a subpopulation of bone marrow cells . 
